Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
March 31, 2026 4.31%
December 31, 2025 18.82%
September 30, 2025 2.21%
June 30, 2025 -65.37%
March 31, 2025 1.23%
December 31, 2024 -5.87%
September 30, 2024 -2.20%
June 30, 2024 -28.20%
March 31, 2024 -17.35%
December 31, 2023 -41.42%
September 30, 2023 -67.04%
June 30, 2023 -18.87%
March 31, 2023 -36.37%
December 31, 2022 -111.1%
September 30, 2022 -25.32%
June 30, 2022 -179.8%
March 31, 2022 -20.49%
December 31, 2021 -39.71%
September 30, 2021 0.23%
June 30, 2021 24.55%
March 31, 2021 -6.64%
December 31, 2020 -14.46%
September 30, 2020 -10.05%
June 30, 2020 -165.1%
March 31, 2020
Date Value
December 31, 2019 -147.5%
September 30, 2019
June 30, 2019 63.45%
March 31, 2019 -332.1%
December 31, 2018 16.37%
September 30, 2018 23.25%
June 30, 2018 22.00%
March 31, 2018 0.09%
December 31, 2017 -17.80%
September 30, 2017 -10.75%
June 30, 2017 -30.03%
March 31, 2017 -36.78%
December 31, 2016 -158.4%
September 30, 2016 -59.29%
June 30, 2016 -86.42%
March 31, 2016 -80.48%
December 31, 2015 -77.00%
September 30, 2015 -79.15%
June 30, 2015 -76.86%
March 31, 2015 -76.78%
December 31, 2014 -59.60%
September 30, 2014 -69.37%
June 30, 2014 -72.89%
March 31, 2014 -27.09%
December 31, 2013 -21.17%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Repligen Corp. 2.45%
Bio-Techne Corp. 17.01%
MindWalk Holdings Corp. -158.7%
Maravai Lifesciences Holdings, Inc. -42.05%
MaxCyte, Inc. -122.0%